What are the primary and secondary headache types, their distinguishing features, and recommended acute and preventive management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Headache: Classification and Clinical Approach

Primary vs. Secondary Headache Disorders

Headaches are classified into primary disorders (migraine, tension-type, cluster) that have no underlying pathology, and secondary disorders caused by identifiable medical conditions—primary headaches account for approximately 90% of presentations, with tension-type affecting 38% and migraine affecting 12-18% of the population. 1, 2, 3


Primary Headache Types

Migraine Without Aura

Diagnosis requires ≥5 lifetime attacks lasting 4-72 hours, with ≥2 pain characteristics (unilateral, pulsating, moderate-to-severe intensity, or worsened by routine activity) AND ≥1 associated feature (nausea/vomiting OR both photophobia and phonophobia). 2, 4

  • Pain characteristics: Unilateral location in most cases, pulsating/throbbing quality, moderate-to-severe intensity that interferes with daily activities 2, 4
  • Key distinguishing features: Photophobia combined with nausea strongly supports migraine over other primary headaches 2
  • Duration: Individual attacks last 4-72 hours if untreated 1, 2
  • Prevalence: Affects 18% of women and 6.5% of men in the United States 4

Migraine With Aura

Requires all features of migraine without aura PLUS recurrent visual/sensory/speech disturbances with ≥3 characteristics: gradual spread over ≥5 minutes, ≥2 symptoms in succession, ≥1 unilateral symptom, ≥1 positive symptom, and aura followed by headache within 60 minutes. 2

  • Critical red flag: Atypical aura lasting >60 minutes or with focal neurological deficits may indicate stroke/TIA and requires urgent neuroimaging 2

Chronic Migraine

Defined as ≥15 headache days/month for >3 months, with ≥8 days meeting migraine criteria—this represents a distinct entity requiring preventive therapy and neurology referral. 2, 4

Tension-Type Headache

Bilateral, pressing/tightening (non-pulsating) pain of mild-to-moderate intensity, NOT aggravated by routine activity, and lacking both nausea/vomiting AND the combination of photophobia plus phonophobia. 2, 4

  • Prevalence: Most common primary headache at 38% of the population 2, 3
  • Key differentiator: Absence of migraine features—no nausea, no worsening with activity, bilateral location 2, 4

Cluster Headache

Strictly unilateral severe-to-very-severe pain lasting 15-180 minutes, occurring 1-8 times daily, with ipsilateral autonomic symptoms (lacrimation, conjunctival injection, nasal congestion, ptosis, miosis). 2, 4

  • Prevalence: Rare at ~0.1% of the population 2, 4
  • Attack frequency: Requires ≥5 attacks meeting criteria for diagnosis 4

Secondary Headache Types and Red Flags

Life-Threatening Causes Requiring Immediate Evaluation

Any patient presenting with thunderclap headache ("worst headache of life"), focal neurological signs, unexplained fever with neck stiffness, altered consciousness, or new-onset headache after age 50 requires emergency evaluation for secondary causes. 2, 4

Subarachnoid Hemorrhage

  • Presentation: Thunderclap onset, may have altered taste sensation 2
  • Imaging: Non-contrast CT within 6 hours has 95% sensitivity (drops to 74% by day 3,50% at 1 week) 2

Meningitis

  • Presentation: Headache with neck stiffness and unexplained fever—requires immediate evaluation 2, 4

Brain Tumor/Space-Occupying Lesion

  • Presentation: Progressive headache, awakens from sleep, worsens with Valsalva/cough 2
  • Pediatric note: Nearly all children with intracranial tumors have additional neurologic signs (94% had abnormal findings, 60% had papilledema) 1

Giant Cell Arteritis

  • Presentation: New-onset headache in patients >50 years with scalp tenderness, jaw claudication 2
  • Caveat: ESR can be normal in 10-36% of cases 2

Increased Intracranial Pressure

  • Presentation: Headache worsening with coughing, sneezing, exercise 2

Spontaneous Intracranial Hypotension

  • Presentation: Orthostatic headache (absent/mild on waking, onset within 2 hours of upright posture, >50% improvement within 2 hours of lying flat) 2

Medication-Overuse Headache

Defined as ≥15 headache days/month with regular overuse of non-opioid analgesics ≥15 days/month OR other acute medications ≥10 days/month for >3 months—this transforms episodic migraine into a chronic daily headache pattern. 2


Diagnostic Approach

History Elements That Determine Headache Type

  • Age at onset: Migraine typically begins at/around puberty 2
  • Duration: Migraine 4-72 hours; cluster 15-180 minutes; tension-type variable 2
  • Location: Unilateral (migraine, cluster) vs bilateral (tension-type) 2, 4
  • Quality: Pulsating (migraine) vs pressing/tightening (tension-type) vs severe unilateral (cluster) 2, 4
  • Aggravating factors: Routine activity worsens migraine but not tension-type 2, 4

Validated Screening Tools

  • ID-Migraine questionnaire (3-item): Sensitivity 0.81, specificity 0.75, positive predictive value 0.93 2
  • Migraine Screen Questionnaire (5-item): Sensitivity 0.93, specificity 0.81, positive predictive value 0.83 2
  • Headache diary: Document frequency, duration, character, triggers, accompanying symptoms, medication use to reduce recall bias 2, 4

Neuroimaging Indications

Neuroimaging is NOT routinely indicated for primary headaches with normal neurological examination—the yield is only 0.2% (2/1086 patients), no higher than 0.4% in asymptomatic volunteers. 2

MRI with and without contrast is preferred for subacute presentations or suspected tumor/inflammatory processes; non-contrast CT is indicated only if presenting <6 hours from acute severe headache onset (subarachnoid hemorrhage). 2, 5

  • Pediatric imaging: Yield of brain MRI is not contributory in children with primary headache and normal examination (<1% had relevant findings) 1
  • No role for CTA, CTV, MRA, MRV, or arteriography in primary headache without concerning examination findings 1

Acute Management by Headache Type

Migraine Acute Treatment

NSAIDs or acetaminophen are first-line for all migraine attacks, including severe attacks that have responded to these agents previously; triptans or ergot derivatives are indicated for moderate-to-severe attacks or when NSAIDs fail. 1, 2

  • NSAIDs with strongest evidence: Aspirin, ibuprofen, naproxen sodium, tolfenamic acid, and combination acetaminophen-aspirin-caffeine 1
  • Acetaminophen alone is ineffective 1
  • Triptans: Oral naratriptan, rizatriptan, sumatriptan, zolmitriptan; subcutaneous/intranasal sumatriptan for patients with nausea/vomiting 1
  • Triptan efficacy: Eliminate pain in 20-30% of patients by 2 hours 3
  • Triptan adverse effects: Transient flushing, tightness, or tingling in upper body in 25% of patients; contraindicated in cardiovascular disease due to vasoconstrictive properties 3
  • Gepants (rimegepant, ubrogepant): Eliminate headache in 20% at 2 hours; adverse effects include nausea and dry mouth in 1-4% 3
  • Lasmiditan (5-HT1F agonist): Safe in patients with cardiovascular risk factors 3
  • Antiemetics: For nausea/vomiting 2

Cluster Headache Acute Treatment

High-flow oxygen (100% at 12-15 L/min) is first-line acute treatment; subcutaneous or intranasal triptans are alternative acute treatments. 2

Preventive Treatment Indications

Preventive therapy is indicated for chronic migraine (≥15 headache days/month) and reduces migraine frequency by 1-3 days per month relative to placebo. 2, 3

  • Options: Antihypertensives, antiepileptics, antidepressants, calcitonin gene-related peptide monoclonal antibodies, onabotulinumtoxinA 3

Referral Pathways

  • Emergency admission: Any red flag present, patient unable to self-care without help 2
  • Urgent neurology referral (within 48 hours): Suspected spontaneous intracranial hypotension, patient unable to self-care but has help 2
  • Routine neurology referral (2-4 weeks): Suspected primary headache disorder, diagnosis uncertain, first-line treatments fail 2
  • Rheumatology referral: Suspected giant cell arteritis 2

Common Pitfalls

  • "Sinus headache" misdiagnosis: Approximately 62% of pediatric migraineurs have cranial autonomic symptoms (rhinorrhea) from trigeminal-autonomic reflex activation—consider migraine before sinusitis 1
  • Overlooking medication-overuse: Regular use of acute medications transforms episodic into chronic headache—requires withdrawal and preventive therapy 2
  • Imaging normal-exam primary headaches: Wastes resources and exposes patients to unnecessary radiation/contrast without changing management 1, 2
  • Missing giant cell arteritis: Normal ESR in 10-36% of cases—clinical suspicion in patients >50 with new headache should prompt rheumatology referral regardless 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Approach to Assessment of Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Headache Classification and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostics and Management of Headaches in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.